Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Tricot

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Prognostic factors in multiple myelomaGuido Tricot
Blood|October 25, 2008
Is more better in myeloma?Guido Tricot
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2010
Comparison of unmobilized and mobilized graft characteristics and the implications of cell subsets on autologous and allogeneic transplantation outcomesStefan Fruehauf, Guido Tricot
Contributions to Nephrology|November 1, 2006
High-dose therapy in patients with plasma cell dyscrasias and renal dysfunctionMauricio Pineda-Roman, Guido Tricot
Leukemia & Lymphoma|September 14, 2004
Chromosome 13 deletion/hypodiploidy and prognosis in multiple myeloma patientsAthanasios B-T Fassas, Guido Tricot
Clinical Advances in Hematology & Oncology : H&O|August 9, 2007
Tandem transplants in the treatment of multiple myeloma. ProAthanasios B-T Fassas, Guido Tricot
Expert Opinion on Investigational Drugs|November 1, 2005
Immunomodulatory drugs in multiple myelomaMaurizio Zangari, Francesca Elice, Guido Tricot
Current Opinion in Supportive and Palliative Care|July 27, 2010
Bone and paraproteinemiasMaurizio Zangari, Fenghuang Zhan, Guido Tricot
Current Pharmaceutical Biotechnology|December 16, 2006
Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myelomaMaurizio Zangari, Federica Cavallo, Guido Tricot
Leukemia & Lymphoma|October 31, 2006
NY-ESO-1 immunotherapy for multiple myelomaSusann Szmania, Guido Tricot, Frits van Rhee
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Prognostic factors in multiple myelomaGuido Tricot
Blood|October 25, 2008
Is more better in myeloma?Guido Tricot
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2010
Comparison of unmobilized and mobilized graft characteristics and the implications of cell subsets on autologous and allogeneic transplantation outcomesStefan Fruehauf, Guido Tricot
Contributions to Nephrology|November 1, 2006
High-dose therapy in patients with plasma cell dyscrasias and renal dysfunctionMauricio Pineda-Roman, Guido Tricot
Leukemia & Lymphoma|September 14, 2004
Chromosome 13 deletion/hypodiploidy and prognosis in multiple myeloma patientsAthanasios B-T Fassas, Guido Tricot
Clinical Advances in Hematology & Oncology : H&O|August 9, 2007
Tandem transplants in the treatment of multiple myeloma. ProAthanasios B-T Fassas, Guido Tricot
Expert Opinion on Investigational Drugs|November 1, 2005
Immunomodulatory drugs in multiple myelomaMaurizio Zangari, Francesca Elice, Guido Tricot
Current Opinion in Supportive and Palliative Care|July 27, 2010
Bone and paraproteinemiasMaurizio Zangari, Fenghuang Zhan, Guido Tricot
Current Pharmaceutical Biotechnology|December 16, 2006
Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myelomaMaurizio Zangari, Federica Cavallo, Guido Tricot
Leukemia & Lymphoma|October 31, 2006
NY-ESO-1 immunotherapy for multiple myelomaSusann Szmania, Guido Tricot, Frits van Rhee
Pageof 18